Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia

被引：43

作者：

Shefer, Abigail ^{[1
]}

Markowitz, Lauri ^{[2
]}

Deeks, Shelley ^{[3
]}

Tam, Theresa ^{[4
]}

Irwin, Kathleen ^{[5
]}

Garland, Suzanne M. ^{[6
]}

Schuchat, Anne ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA

[2] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA

[3] Publ Hlth Agcy Canada, Ctr Infect Dis Prevent & Control, Immunisat & Resp Div, Ottawa, ON, Canada

[4] Publ Hlth Agcy Canada, Ctr Infect Dis Prevent & Control, Immunizat & Resp Infect Div, Ottawa, ON, Canada

[5] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland

[6] Univ Melbourne, Dept Obstet & Gynaecol, Royal Hosp Women, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia

来源：

VACCINE | 2008年 / 26卷

关键词：

Human Papillomavirus; Vaccine; Vaccine schedule; Financing; Implementation;

D O I：

10.1016/j.vaccine.2008.05.065

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Successful incorporation of a new vaccine into a nation's vaccination program requires addressing a number of issues, including: 1) establishing national recommendations; 2) assuring education of and acceptance by the public and medical community; 3) establishing and maintaining an appropriate infrastructure for vaccine delivery; 4) financing the vaccine and the program, in addition to political will. This article reviews the early experience with implementation of human papillomavirus (HPV) vaccination programs. It focuses on the United States of America and Canada and provides a brief report on Australia, where introduction is underway. Published by Elsevier Ltd.

引用

页码：K68 / K75

页数：8

共 50 条

[31] Early smallpox vaccine manufacturing in the United States: Introduction of the "animal vaccine" in 1870, establishment of "vaccine farms", and the beginnings of the vaccine industry
Esparza, Jose
Lederman, Seth
Nitsche, Andreas
Damaso, Clarissa R.
VACCINE, 2020, 38 (30) : 4773 - 4779
[32] Human Papillomavirus Vaccine Introduction - The First Five Years
Markowitz, Lauri E.
Tsu, Vivien
Deeks, Shelley L.
Cubie, Heather
Wang, Susan A.
Vicari, Andrea S.
Brotherton, Julia M. L.
VACCINE, 2012, 30 : F139 - F148
[33] Efficacy and other milestones for human papillomavirus vaccine introduction
Pagliusi, SR
Aguado, MT
VACCINE, 2004, 23 (05) : 569 - 578
[34] Association of State Legislation of Human Papillomavirus Vaccination with Vaccine Uptake Among Adolescents in the United States
Nadja A. Vielot
Anne M. Butler
Justin G. Trogdon
Ramya Ramadas
Jennifer S. Smith
Amy Eyler
Journal of Community Health, 2020, 45 : 278 - 287
[35] The Uptake of Human Papillomavirus (HPV) Vaccine Among Adolescent Females in the United States: A Review of the Literature
Bartlett, Jacqueline A.
Peterson, Jane Anthony
JOURNAL OF SCHOOL NURSING, 2011, 27 (06): : 434 - 446
[36] FEDERAL GRANTS IN CANADA, AUSTRALIA, AND UNITED-STATES
MAXWELL, JA
PUBLIUS-THE JOURNAL OF FEDERALISM, 1974, 4 (02) : 63 - 75
[37] MULTICULTURAL MULTIPLICITIES - UNITED-STATES, CANADA, AUSTRALIA
GUNEW, S
MEANJIN, 1993, 52 (03): : 447 - 461
[38] Safety and Success of the Human Papillomavirus Vaccine: Time for a Robust Vaccination Program in the United States and Worldwide
Duska, Linda R.
CLINICAL THERAPEUTICS, 2014, 36 (01) : 4 - 7
[39] The State as Arbitrator of Disputes in the United States, Canada and Australia
不详
JOURNAL OF POLITICAL ECONOMY, 1915, 23 (03) : 301 - 302
[40] Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States
Seeger, John D.
Amend, Kandace L.
Turnbull, Bruce R.
Zhou, Li
Marks, Morgan A.
Velicer, Christine
Saddier, Patricia
VACCINE, 2023, 41 (11) : 1826 - 1833

← 1 2 3 4 5 →